Biosimilars Market- by Product (Recombinant non-glycosylated proteins, Recombinant peptides, Recombinant glycosylated proteins), by Manufacturing type (Contract manufacturing organizations, In-house manufacturing), by Application (Blood disorders, Growth hormone deficiency, Oncology, Chronic & autoimmune diseases, Infectious diseases, Others) - Global Industry Perspective Comprehensive Analysis and Forecast, 2020 - 2026
Published Date: 04-Dec-2020Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-1290
Status : Published
According to the report, global demand for the Biosimilars market was valued at approximately USD 9.8 billion in 2019 and is expected to generate revenue of around USD 43.1 billion by end of 2026, growing at a CAGR of around 23.6 % between 2020 and 2026.